Literature DB >> 3398198

Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic.

H F Hull1, C J Bettinger, M M Gallaher, N M Keller, J Wilson, G J Mertz.   

Abstract

All patients attending a sexually transmitted disease (STD) clinic were offered voluntary, anonymous human immunodeficiency virus (HIV)-antibody testing and counseling as part of routine clinical evaluation. During a three-month evaluation period, 82% of patients accepted HIV testing. Testing was accepted equally by men and women and by heterosexual and homosexual men. Black men were more likely to refuse testing than men from other ethnic groups. Eight (0.7%) of 1146 STD clinic patients tested were infected with HIV. A blinded study of 237 patients who refused testing identified nine (3.8%) additional HIV-infected patients. Men who refused testing were 5.3 times more likely to be infected than men who accepted testing. Male homosexuals and black and Hispanic men who refused testing were 7.3 and 8.8 times, respectively, more likely to be infected with HIV than were their counterparts who accepted testing. Human immunodeficiency virus testing and counseling should be routinely offered to STD clinic patients. Male STD clinic patients, especially homosexual or minority men, who refuse voluntary HIV testing should be counseled regarding reducing their risk for HIV transmission.

Entities:  

Keywords:  Bernalillo County Health Office; Empirical Approach; Health Care and Public Health

Mesh:

Year:  1988        PMID: 3398198

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  43 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  [HIV infection: feasibility of a seroprevalence study with consent of hospitalized patients].

Authors:  L Saghafi; A Maziero; P Francioli
Journal:  Soz Praventivmed       Date:  1992

3.  Serosurveillance of human immunodeficiency virus infection.

Authors:  T J Dondero; J W Curran
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

4.  Ethics and ethics committees: HIV serosurveillance in Scotland.

Authors:  D M Tappin; F Cockburn
Journal:  J Med Ethics       Date:  1992-03       Impact factor: 2.903

5.  Seroprevalence of HIV-1 infection in a cohort of homosexually active men.

Authors:  A J Hunt; G Christofinis; A P Coxon; P M Davies; T J McManus; S Sutherland; P Weatherburn
Journal:  Genitourin Med       Date:  1990-12

6.  Primary prevention of HIV-1 infection among intravenous drug users.

Authors:  W W Wiebel; T M Lampinen
Journal:  J Prim Prev       Date:  1991-09

7.  Voluntary confidential HIV testing of STD patients in Switzerland, 1990-5: HIV test refusers cause different biases on HIV prevalences in heterosexuals and homo/bisexuals. Swiss Network of Dermatovenereology Policlinics.

Authors:  W J Paget; M Zwahlen; A R Eichmann
Journal:  Genitourin Med       Date:  1997-12

8.  College students and HIV testing: cognitive, emotional self-efficacy, motivational and communication factors.

Authors:  Carolyn A Lin; Deya Roy; Linda Dam; Emil N Coman
Journal:  J Commun Healthc       Date:  2017-10-04

9.  Seroprevalence of HIV-type 1 in a northern California health plan population: an unlinked survey.

Authors:  R A Hiatt; F J Capell; M S Ascher
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

10.  HIV infection in patients attending clinics for sexually transmitted diseases in England and Wales 1988. A Collaborative Study by Consultants in Genitourinary Medicine and the Public Health Laboratory Service.

Authors: 
Journal:  Genitourin Med       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.